Porcine circovirus type 3 immunogenic compositions and methods of making and using the same
AssigneeKansas State University Research Foundation
InventorBen Hause
Life of this patent
Estimating the term…
Abstract
A new species of circovirus, porcine circovirus type 3 (PCV3), was identified from sows with clinical symptoms normally associated with porcine circovirus type 2 (PCV2) infection and in aborted fetuses. Molecular and serological analyses suggest PCV3 commonly circulates in U.S. swine. The present disclosure provides immunological compositions and methods related to the production and administration of such compositions.
Claims53
A method of inducing an immunological response against porcine circovirus type 3 comprising the steps of:
- administering to an animal a composition comprising a protein, wherein the protein comprises an amino acid sequence having at least 90% sequence identity with SEQ ID NO. 6.
A method of inducing an immunological response against porcine circovirus type 3 comprising the steps of:
- administering to an animal a composition comprising a protein, wherein the protein is encoded by a nucleotide sequence having at least 90% sequence identity with SEQ ID NO. 5.
A method of inducing an immunological response against porcine circovirus type 3 comprising the steps of:
- administering to an animal a composition comprising a vector comprising a heterologous nucleotide sequence encoding a protein, wherein the protein comprises an amino acid sequence having at least 90% sequence identity with SEQ ID NO. 6.
A method of inducing an immunological response against porcine circovirus type 3 comprising the steps of:
- administering to an animal a composition comprising a vector comprising a heterologous nucleotide sequence having at least 90% sequence identity with SEQ ID NO. 5.
A method of inducing an immunological response against porcine circovirus type 3 comprising the steps of:
- administering to an animal a composition comprising a vector comprising a heterologous RNA sequence corresponding to a nucleotide sequence having at least 90% sequence identity with SEQ ID NO. 5.
Dependencies are inferred from the claim text.